Oct. 1, 2019 Price forecast | 2 weeks: -0.98% | 1 month: -0.47% | 3 months: -0.44%


DOVA stock forecast

Our latest prediction for Dova Pharmaceuticals, Inc.'s stock price was made on the Oct. 1, 2019 when the stock price was at 27.87$.

In the short term (2weeks), DOVA's stock price should underperform the market by -0.98%. During that period the price should oscillate between -12.36% and +14.92%.

In the medium term (3months), DOVA's stock price should underperform the market by -0.44%. During that period the price should oscillate between -22.97% and +31.66%.


About Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC.

At the moment the company generates 13M USD in revenues.

On its last earning announcement, the company reported a loss of -2.56$ per share.

The book value per share is 3.89$

Dova Pharmaceuticals, Inc. website


Three months stock forecastOct. 1, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
13M 87.80% -72M -539.20% -72M -2.56 - - 28M 3.89 -58M - -58M